Debt to capital ratio of 35 drug makers eased in 2006

Published: 2008-02-20 06:59:00

Updated: 2008-02-20 06:59:00

The debts to capital ratio of 35 KSE-listed pharmaceutical firms in 2006 averaged 61.0 percent an improvement of 3.5 percentage points from 2005 and their debts totaled 2,805 billion won in 2006, according to data released by the Korea Health Industry Development Institute.

The debts to capital ratio of 20 KOSDAQ-listed pharmaceutical firms in 2006 stood at 37.8 percent, indicating that...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.